SEC Form 4 · accession 0001131096-15-000095
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Cosinuke
Officer — SVP, Chief Marketing Officer
Period of report
Apr 6, 2015
Accepted (ET)
Apr 8, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 6, 2015 | M | 6,000 | $25.67 | A | 46,322 | D | |
| Common StockF1,F2 | Apr 6, 2015 | S | 1,300 | $117.50 | D | 45,022 | D | |
| Common StockF1,F3 | Apr 6, 2015 | S | 1,600 | $118.85 | D | 43,422 | D | |
| Common StockF1,F4 | Apr 6, 2015 | S | 1,450 | $119.79 | D | 41,972 | D | |
| Common StockF1,F5 | Apr 6, 2015 | S | 1,650 | $120.58 | D | 40,322 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $25.67 | Apr 6, 2015 | M | 6,000 | D | Jan 5, 2010 | Mar 2, 2019 | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on October 21, 2014, in accordance with Rule 10b5-1.
- F2This price represents the weighted average of sales ranging from $117.15 to $117.75. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average of sales ranging from $118.24 to $119.19. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average of sales ranging from $119.34 to $120.32. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average of sales ranging from $120.37 to $120.98. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.